Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetoshi Nitta

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Annals of Surgical Oncology|July 27, 2013
Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosisShigeki Nakagawa, Hirohisa Okabe, Yasuo Sakamoto, et al.
International Journal of Clinical Oncology|July 18, 2013
Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institutionHirohisa Okabe, Toru Beppu, Akira Chikamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 20, 2013
Triple positive tumor markers predict recurrence and survival in early stage hepatocellular carcinomaShigeki Nakagawa, Toru Beppu, Hirohisa Okabe, et al.
Medical Oncology (Northwood, London, England)|October 1, 2016
Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomesHidetoshi Nitta, Takayuki Shimose, Yasunori Emi, et al.
International Journal of Clinical Oncology|September 4, 2013
The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancersYoshiaki Ikuta, Hiroshi Takamori, Yasuo Sakamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[The Usefulness of RFA as a Conversion Therapy after Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma-A Case of Long-Term Survival with Multidisciplinary Treatment]Takashi Matsumoto, Hiromitsu Hayashi, Yuki Adachi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2013
Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88)Hidetoshi Nitta, Yoshihiro Wada, Yoshiaki Kawano, et al.
International Cancer Conference Journal|April 8, 2020
Renal metastasis from intrahepatic cholangiocarcinomaChihiro Matsumoto, Katsunori Imai, Yosuke Nakao, et al.
Surgery|March 18, 2019
Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantationHidetoshi Nitta, Marc-Antoine Allard, Mylène Sebagh, et al.
Annals of Surgical Oncology|May 5, 2019
Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular CarcinomaHidetoshi Nitta, Marc-Antoine Allard, Mylène Sebagh, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|July 27, 2013
Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosisShigeki Nakagawa, Hirohisa Okabe, Yasuo Sakamoto, et al.
International Journal of Clinical Oncology|July 18, 2013
Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institutionHirohisa Okabe, Toru Beppu, Akira Chikamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 20, 2013
Triple positive tumor markers predict recurrence and survival in early stage hepatocellular carcinomaShigeki Nakagawa, Toru Beppu, Hirohisa Okabe, et al.
Medical Oncology (Northwood, London, England)|October 1, 2016
Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomesHidetoshi Nitta, Takayuki Shimose, Yasunori Emi, et al.
International Journal of Clinical Oncology|September 4, 2013
The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancersYoshiaki Ikuta, Hiroshi Takamori, Yasuo Sakamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[The Usefulness of RFA as a Conversion Therapy after Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma-A Case of Long-Term Survival with Multidisciplinary Treatment]Takashi Matsumoto, Hiromitsu Hayashi, Yuki Adachi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2013
Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88)Hidetoshi Nitta, Yoshihiro Wada, Yoshiaki Kawano, et al.
International Cancer Conference Journal|April 8, 2020
Renal metastasis from intrahepatic cholangiocarcinomaChihiro Matsumoto, Katsunori Imai, Yosuke Nakao, et al.
Surgery|March 18, 2019
Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantationHidetoshi Nitta, Marc-Antoine Allard, Mylène Sebagh, et al.
Annals of Surgical Oncology|May 5, 2019
Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular CarcinomaHidetoshi Nitta, Marc-Antoine Allard, Mylène Sebagh, et al.
Pageof 13